Alterity Therapeutics Ltd (ATHE) stock
ATHENasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as PRNAF
$1.86−0.09 (-4.85%)
Close on Nov 17, 2026Market cap $33.80MP/E –Yield –
Alterity Therapeutics pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Alterity Therapeutics's pe ratio was 69.7× on Aug 30, 2024, against 66.6× a year earlier. Over the last 5 years it ranged from 0.7× to 69.7×, with a median of 2.0×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2024 | Aug 30, 2024 | 69.7× | +16.0 |
| 2023 | Dec 29, 2023 | 53.7× | +52.1 |
| 2022 | Dec 30, 2022 | 1.6× | −0.7 |
| 2021 | Dec 31, 2021 | 2.3× | +0.3 |
| 2020 | Dec 31, 2020 | 1.9× | +1.0 |
| 2019 | Dec 31, 2019 | 0.9× | – |
See a number that looks wrong?